Time for Top Leaders to Join Pandemic Negotiations
Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.
European Patients’ Rights Day: Addressing skills shortage, medical desertification and job strain
Ahead of European Patients’ Rights Day, Mariano Votta, Director of Active Citizenship Network, discusses how the event will tackle the skills shortage, medical desertification and job strain in the healthcare sector.
European Immunization Week 2024: Prevent. Protect. Immunise
WHO European Region celebrates the European Immunization Week in April to promote awareness of the importance of immunisation in preventing diseases and protecting life.
COVID-19 Shows Why the World Needs a Pandemic Agreement
Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.
Overcoming the COVID-19 pandemic together and building a Health Union
In 2020, the world was hit by the worst pandemic of our generation. At the heart of the European Commission’s response to COVID-19 were cooperation and solidarity.
Call for expression of interest – Members representing non-governmental organisations in the Advisory Forum of the European Centre for Disease Prevention and Control
The European Commission has launched a call for expression of interest aiming at the selection of the ECDC Advisory Forum members.
In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months
Uptake of COVID-19 vaccines among pregnant individuals was hampered by safety concerns around potential risks to unborn children.
Cryptic proteins translated from deletion-containing viral genomes dramatically expand the influenza virus proteome
Scientific Papers
Article
Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Disea
Influenza affects millions of people worldwide each year and can lead to severe complications, hospitalizations, and even death, especially among vulnerable populations such as older adults and those with chronic medical conditions.
Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The purpose of NIRSE-GAL is to evaluate the impact of the inclusion of nirsevimab in the Galician immunisation schedule on the prevention of Respiratory Syncytial Respiratory Syncytial Virus (RSV) infections in children.
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
COVID-19 vaccines have recently been updated to specifically encode or contain the spike protein of the SARS-CoV-2 XBB.1.5 subvariant.